- Home
- VSTM vs GLRE Comparison
VSTM vs GLRE Comparison
Compare VSTM & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- GLRE
- Stock Information
- Founded
- VSTM 2010
- GLRE 2004
- Country
- VSTM United States
- GLRE Cayman Islands
- Employees
- VSTM N/A
- GLRE N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- GLRE Property-Casualty Insurers
- Sector
- VSTM Health Care
- GLRE Finance
- Exchange
- VSTM Nasdaq
- GLRE Nasdaq
- Market Cap
- VSTM 425.9M
- GLRE 466.5M
- IPO Year
- VSTM 2012
- GLRE 2007
- Fundamental
- Price
- VSTM $4.93
- GLRE $14.40
- Analyst Decision
- VSTM Strong Buy
- GLRE
- Analyst Count
- VSTM 8
- GLRE 0
- Target Price
- VSTM $12.71
- GLRE N/A
- AVG Volume (30 Days)
- VSTM 2.6M
- GLRE 112.1K
- Earning Date
- VSTM 08-07-2025
- GLRE 08-05-2025
- Dividend Yield
- VSTM N/A
- GLRE N/A
- EPS Growth
- VSTM N/A
- GLRE N/A
- EPS
- VSTM N/A
- GLRE 1.32
- Revenue
- VSTM $10,000,000.00
- GLRE $717,617,000.00
- Revenue This Year
- VSTM $129.06
- GLRE N/A
- Revenue Next Year
- VSTM $306.32
- GLRE N/A
- P/E Ratio
- VSTM N/A
- GLRE $10.94
- Revenue Growth
- VSTM N/A
- GLRE 2.79
- 52 Week Low
- VSTM $2.10
- GLRE $11.95
- 52 Week High
- VSTM $9.10
- GLRE $15.82
- Technical
- Relative Strength Index (RSI)
- VSTM 30.80
- GLRE 55.37
- Support Level
- VSTM $5.73
- GLRE $14.35
- Resistance Level
- VSTM $6.62
- GLRE $15.07
- Average True Range (ATR)
- VSTM 0.46
- GLRE 0.29
- MACD
- VSTM -0.17
- GLRE -0.04
- Stochastic Oscillator
- VSTM 0.84
- GLRE 37.38
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.